Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 02:09PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-5.64 Insider Own3.27% Shs Outstand14.66M Perf Week1.05%
Market Cap380.05M Forward P/E30.30 EPS next Y0.86 Insider Trans0.00% Shs Float14.16M Perf Month3.47%
Income-82.67M PEG- EPS next Q-0.08 Inst Own93.36% Short Float5.44% Perf Quarter11.99%
Sales166.66M P/S2.28 EPS this Y192.22% Inst Trans-0.70% Short Ratio9.29 Perf Half Y39.57%
Book/sh14.48 P/B1.79 EPS next Y209.64% ROA-26.02% Short Interest0.77M Perf Year-2.74%
Cash/sh4.98 P/C5.22 EPS next 5Y10.00% ROE-33.21% 52W Range16.54 - 28.12 Perf YTD14.56%
Dividend Est.- P/FCF- EPS past 5Y- ROI-34.56% 52W High-7.70% Beta0.74
Dividend TTM- Quick Ratio3.76 Sales past 5Y9.62% Gross Margin61.85% 52W Low56.95% ATR (14)0.66
Dividend Ex-Date- Current Ratio5.26 EPS Y/Y TTM-453.72% Oper. Margin-15.27% RSI (14)55.69 Volatility1.84% 2.22%
Employees357 Debt/Eq0.14 Sales Y/Y TTM6.67% Profit Margin-49.60% Recom1.67 Target Price30.33
Option/ShortYes / Yes LT Debt/Eq0.13 EPS Q/Q-1183.17% Payout- Rel Volume0.19 Prev Close25.79
Sales Surprise3.78% EPS Surprise122.06% Sales Q/Q8.45% EarningsMay 08 AMC Avg Volume82.92K Price25.96
SMA201.17% SMA502.55% SMA20017.42% Trades Volume11,690 Change0.66%
Date Action Analyst Rating Change Price Target Change
Aug-14-23Upgrade Barrington Research Mkt Perform → Outperform $24
Mar-07-23Downgrade Barrington Research Outperform → Mkt Perform
Nov-09-22Upgrade Barrington Research Mkt Perform → Outperform $31
Oct-14-22Resumed Stephens Equal-Weight $26
Mar-09-22Downgrade Stephens Overweight → Equal-Weight $35
Mar-09-22Downgrade Barrington Research Outperform → Mkt Perform
Nov-16-21Initiated Stephens Overweight $55
Jul-16-21Initiated UBS Neutral $46
Dec-16-20Upgrade Barrington Research Mkt Perform → Outperform $43
May-08-20Downgrade Barrington Research Outperform → Mkt Perform
Apr-18-24 04:01PM
Apr-02-24 08:00AM
Mar-16-24 03:15PM
Mar-14-24 08:18AM
Mar-13-24 04:47PM
04:05PM Loading…
Mar-08-24 04:01PM
Feb-27-24 04:01PM
Feb-13-24 09:00AM
Nov-28-23 09:00AM
Nov-07-23 04:05PM
Nov-05-23 02:26PM
Nov-03-23 09:43AM
Nov-02-23 06:11PM
04:05PM Loading…
Oct-10-23 09:00AM
Oct-04-23 07:18AM
Oct-03-23 09:11AM
Sep-19-23 09:00AM
Sep-15-23 07:44PM
Sep-12-23 09:00AM
Sep-01-23 06:51PM
Aug-31-23 12:00PM
Aug-22-23 07:22AM
Aug-17-23 06:20PM
11:02AM Loading…
Aug-14-23 09:59AM
Aug-11-23 07:07AM
Aug-09-23 09:03AM
Aug-08-23 06:55PM
Aug-03-23 07:33PM
Jul-20-23 04:05PM
Jul-12-23 09:00AM
Jun-21-23 08:00PM
May-30-23 04:05PM
May-15-23 09:19AM
May-09-23 07:15PM
Apr-26-23 08:00PM
Apr-19-23 11:32AM
Apr-13-23 05:44PM
Apr-12-23 09:00AM
Apr-03-23 09:00AM
Mar-27-23 04:55PM
Mar-20-23 06:15PM
Mar-18-23 10:08AM
Mar-15-23 04:01PM
Mar-08-23 10:00AM
Mar-07-23 09:52AM
Mar-06-23 05:45PM
Feb-28-23 09:00AM
Feb-27-23 06:15PM
Feb-21-23 06:15PM
Feb-20-23 09:25AM
Feb-14-23 06:15PM
Feb-13-23 08:30AM
Feb-07-23 06:15PM
Jan-30-23 06:15PM
Jan-17-23 09:40AM
Jan-09-23 10:04AM
Dec-28-22 07:05AM
Nov-10-22 01:24PM
Nov-08-22 07:35PM
Nov-01-22 12:14PM
Oct-25-22 09:25AM
Oct-17-22 01:13PM
Oct-11-22 09:41AM
Sep-12-22 04:01PM
Aug-03-22 05:45PM
Jul-27-22 09:15AM
Jul-21-22 07:20AM
Jul-19-22 10:42AM
Jul-12-22 05:05PM
Jun-14-22 02:45PM
Jun-10-22 09:27AM
May-20-22 03:07PM
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Colleran DavidEVP, General Counsel, Corp SecMar 11 '24Option Exercise0.0016,809035,245Mar 12 08:03 PM
Blanchard Cheryl RPresident, CEO, DirectorMar 11 '24Option Exercise0.0064,4800166,228Mar 12 08:04 PM
Nunes AnneSVP, Chief Operations OfficerMar 11 '24Option Exercise0.005,856011,838Mar 12 08:02 PM
Levitz Michael LEVP, CFO, TreasurerMar 11 '24Option Exercise0.0019,201049,565Mar 12 08:01 PM
Nunes AnneSVP, Chief Operations OfficerOct 01 '23Option Exercise0.002,49105,784Oct 03 04:31 PM
Levitz Michael LEVP, CFO, TreasurerAug 10 '23Option Exercise0.003,859034,365Aug 11 04:30 PM
Blanchard Cheryl RPresident, CEO, DirectorApr 26 '23Option Exercise0.0024,5750125,155Apr 28 04:30 PM